Another phase III, randomized, open-label, non-inferiority, head-to-head trial, AWARD-6, evaluated dulaglutide (1.5 mg) versus liraglutide (1.8 mg) in patients with T2DM
Fontenot said Louisiana had not yet taken any legal or regulatory action against compounding pharmacies in the state
Why Your GLP-1 Strategy Matters More Than You Think GLP-1 medications can reduce appetite and help the scale move quickly
This enzyme acts to slow down fat cell metabolism (fat burning)
Meal-prepping and workout classes are great, but if they havent provided the outcomes youve been looking for, you may need one special resource to tip the scales in your favor
It is under investigation for its effects on energy balance, glucose control, and body weight regulation, positioning it at the frontier of polypeptide-based research